Publicacións en colaboración con investigadores/as de Hospital Universitario de Valladolid (72)

2024

  1. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    Pediatric Blood and Cancer, Vol. 71, Núm. 8

  2. Comparative assessment of phenotypic markers in patients with chronic inflammation: Differences on Bifidobacterium concerning liver status

    European Journal of Clinical Investigation

  3. Comparison of Metabolic Syndrome, Autoimmune and Viral Distinctive Inflammatory Related Conditions as Affected by Body Mass Index

    Journal of Clinical Medicine, Vol. 13, Núm. 21

  4. Data analysis from the Spanish Registry of Cardiac Surgery (RECC) 2021-2023

    Cirugia Cardiovascular

  5. Human T-lymphotropic virus-1 infection among Latin American pregnant women living in Spain

    IJID Regions, Vol. 10, pp. 146-149

  6. Modulatory role of Faecalibacterium on insulin resistance and coagulation in patients with post-viral long haulers depending on adiposity

    iScience, Vol. 27, Núm. 8

  7. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  8. Surgical vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 21, pp. 2472-2485

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  3. Economic Burden of the 2020 COVID-19 Hospitalizations in Spain

    JAMA network open, Vol. 6, Núm. 1, pp. e2250960

  4. Increase in driving after cocaine use in Spain: a cross-sectional dataset analysis for 2021

    Frontiers in Public Health, Vol. 11

  5. Medication economic burden of antidepressant non-adherence in Spain

    Frontiers in Pharmacology, Vol. 14

  6. Prevalence and cost of hospitalized patients with asymptomatic COVID-19 in 2020 in Spain

    Frontiers in Public Health, Vol. 11

  7. The slowdown of new infections by human retroviruses has reached a plateau in Spain

    Journal of Medical Virology, Vol. 95, Núm. 5

  8. Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019

    Pharmaceuticals, Vol. 16, Núm. 4

2022

  1. Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival

    Medicina (Lithuania), Vol. 58, Núm. 6

  2. Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality

    Critical Care, Vol. 26, Núm. 1

  3. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network

    International Journal of Infectious Diseases, Vol. 122, pp. 970-975

  4. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78